ramin: because of the growth in the inflation.hey are buying etf's of the nikkei 400 -- in other words, they are directly injecting capital into the companies which have created this rou friendly corporate governance -- that is a nice way of rewarding those companies. the next step is if they run out of bonds to buy, and they are already buying more by a fairly large margin, is to buy equity. that is why you are bullish. i want to talk about a technicality to the bond buying -- the boj is set to have half the market by 2017. you asked the question when did they struggle -- how soon is that? is it a matter of months? ramin: the question is what is the marginal benefit. i think it would be fairly limited and that is probably why they have looks to shock markets, but buying other assets inequities. what else can they buy? jonathan: the credit market is markable right now. out, very dovish. -- boj, they should do more is it a bailout for the high-yield space? ramin: the european high-yield markets are very attractive. we would like to

catherine, i hand it back to you. >> thanks, ramin.you to play the drums. >>> all right, a writer from belarus has won this year's nobel prize in literature. svetlana alexievich is an author who wrote about the difficulties people had living under the former communist regime in the soviet union. >> the nobel prize in literature for 2015 is awarded to the belarusian writer svetlana alexievich for her writings "a monument to suffering and courage in our time." >> alexievich was born in ukraine and later moved with her family to belarus. while recording as a reporter for a newspaper, she wrote her first book, "the unwomanly face of the war," but it was soon banned by the government. her best-known work is "the chernobyl prayer" depicting the sufferings of people following the nuclear disaster in her homeland. fans of japanese writer haruki murakami gathered in a bookstore in tokyo to watch the announcement. many were disappointed to not hear his name called again. nhk world's yuji spoke to some of murakami's supporters. >> translator: i'm

>> good morning to you, too, ram ramin. the dollar and stocks rose right after the fomc statement and i'm seeing a pretty good morning in tokyo as stocks are kicking off the day higher and it's thursday october 29th. the nikkei is opening up above the 19,000 level, up 6 cents of a percent and the broader topics is up half a percent. let's see how other regional benchmarks are looking at this morning and the south korean kospi is up. and the csx is up rather slightly. we're seeing a positive morning after rallies in new york. the dow closed up over 1% and that's almost 200 points and closed at its highest level since july and the nasdaq finished 1.3% higher, but if you take a closer look at the chart, ramin, it shows the dow wiped out the daily gains right after the statement. u.s. government bond price s extended early losses. in the commodity sector gold paired gains and turned lower because the dollar jumped and that's because the fed left the door open for a rate hike in december. market players say they were pretty surp

ramin mellegard joins us now for business. good morning, fill us in, what are the latest developments of this free trade deal? >> still major issues they have to deal with. and that's going to take some time. ministers ended their first day on wednesday after meeting for just 40 minutes followed by one-on-one makings. and now they've started their second day. ministers are trying to narrow some of the differences on several issues. let's look at some of them. the main ones include the length of patent protection for drugs developed through biotechnology and tariffs on dairy products. some negotiators say they might need more time before they can find some middle ground. japanese government sources say the u.s. is adamant about extending that period when drugs patents are protected. they also say nations remain at odds with new zealand over dairy products. the country wants to see an increase in their exports. now some negotiators say they don't expect to see a broad agreement unless the u.s. makes certain concessions. >>> econ

>> good morning, ramin. machine reorders came in far below analysts and most analysts were expecting -- japan -- the japanese economy might be slipping into recession. let's take a look at the opening levels here in tokyo on this thursday october 8th. both thepix is opening with 18,267 and both indices snapped their winning streak and we're likely to see profit taking that may cap gains today and now that the bank of japan has kept its easing policy unchanged. after the markets closed yesterday bank of japan governor expressed confidence in japan's economic prospects and according to data compiled before his news conference about 50% of the polled economists speculated additional easing at the boj's next meeting in three weeks. however, some analysts i spoke to after the news conference said the numbers of such respondents fell after the news conference. although some are still speculating easing at the boj's meeting on october 30th, others think that the easing will take place next year and we may see more

ramin -- ramin in a sense year with katya kazakina, and we will be back in just a moment. ♪ . ♪ bettym bloomberg world headquarters you're watching the bloomberg market day. let start with the first word news. vonnie passmore from our news desk. -- has more from our news desk bushin vonnie: jeb imposing a pay cut. canceling some fundraisers. he was once the front-runner but trails badly in the polls. a new poll on the republican campaign has donald trump in an unfamiliar situation. second-place. ben carson has stormed in front of donald trump to take a commanding lead in iowa according to a bloomberg politics and des moines register poll. carson is a 28% of likely gop caucus participants, up 10%. trump at 19% and they are followed by ted cruz. former rhode island governor lincoln chafee is ending his campaign for the democratic nomination. he is struggled to raise money and well behind hillary clinton and bernie sanders. a monster hurricane taking aim at mexico's central pacific coast, hurricane patricia could come on shore as early as this afternoon, a category five storm. forecaster

division iii scores, bow beats ramin 42-zero. they have scored more than 40 points in all escape' s this couple other scores we got, campbell taking down farmington-nute. franklin takes down mascoma valley 25-8. kansas city -- we will get to that in a second. newport takes down stevens 42-12. kansas city in toronto, the royals are leading the blue jays 6-3. we will show you the highlights later on tonight. couple of other notes, the bruins have brad coming back tonight from a concussion. on the patriots, terrel brown going on season ending season reserve. stephanie: that does it for news 9 at 6:00. join us back at 11:00. [captioning performed by the national captioning institute, which is responsible for its caption content and accuracy. tt2watv# 1d bt@qz$( tt2watv# 1d "a@qj(l tt2watv# 1d bm@qa#@ tt4watv# 1d " dztq st0 tt4watv# 1d " entq #pp tt4watv# 1d " gzt& :w( tt4watv# 1d " hnt& *yd tt4watv# 1d " iztq @0< tt4watv# 1d " jntq r@\

ramin mellegard joins us with all the details. >> the numbers slightly bigger than we all expected. let's go into the details here. volkswagen says it's going to recall a total of 8.5 million diesel vehicles in the european union. the cars may contain software intended to manipulate emissions test results. volkswagen issued a statement for recalls across the 28-nation european union. the company says it will approach customers and provide further information. the automaker says it will repair vehicles at the request of users in germany but the regular body said it should recall all vehicles in question. volkswagen installed illegal software in its diesel cars to evade emissions tests. some 11 million vehicles around the world may use the softwar y softwarery. >>> let's check the markets. a quick recap on trading in the u.s., let's go through some of the numbers here. global stocks resume their rally on thursday with u.s. indexes closing up over 1%. speculation the u.s. federal reserve will delay an interest rate hike helped lift shares. now in asia, markets kick off final trading da

ramin mellegard joins us. >> quite a slew of data for investors to take in. at the end of the month, we get a sense of cost of goods, job situations and a lot of other items. the leading gauge of inflation was down for the second month in a row. officials at the internal affairs ministry say the consumer price index fell from 0.1% from the same month last year. the figure had been on the rise for 25 consecutive months until june. the index doesn't factor in fresh food because the price of this commodity tends to be volatile. the gauge posted an increase of zeer -- 0.9% year on year. japanese shoppers were watching their wallets last month. household spending figures for september was down 0.4% in yen terms from a year ago. now, households with two or more members spend an average of about 274,000 yen or around $2,300. the ministry officials say the unemployment rate in september was 3.4% unchange from the previous month. officials at the labor ministry say the ratio of job offers for people looking for work was up from august 1.24. there were 124 job opening

ramine for 55 years to treat his wilson's disease. in may, he was paying $366 a month for cupramine. today he is forced to pay $1,800 a month just to stay alive. same drug, same dosage. $366 a month not too long ago. today $1,800 a month just to stay alive. it's not just mr. mannis who is left on the hook to pay for his medicine which has more than quadrupled in costs. taxpayer funded medicare program will now be spending $35,000 a month to cover its portion of his pills because current law prohibits medicare because of the power of the drug companies in this institution, present law prohibits medicare from negotiating more favorable drug prices. cupramine is not a cure for wilson's disease. mr. mannis must take this drug for the rest of his life. it doesn't cure him, but it keeps him alive. valiant did nothing to improve this doing. it's been around for decades. they have done nothing to invest in a cure. instead, the company bought the rights to an existing medicine and raised its price. remember i said in may, mr. mannis was paying